January 18, 2021

Ryvu Therapeutics project regarding Phase I/II clinical study of SEL120 (RVU 120) in solid tumors recommended for financing by NCBiR

Year

2021

Assets in this page

Download assets

  • pdf file

    Current Report ESPI 04/2021

    Download